The available evidence does not support the claim of Nitikin et al that 4CMenB is a cost-effective way to reduce Gonorrhea incidence

C Kenyon

doi:10.1093/infdis/jiaf199

The available evidence does not support the claim of Nitikin et al that 4CMenB is a cost-effective way to reduce Gonorrhea incidence

Sexually Transmitted Infections

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	Journal of Infectious Diseases
Number of pages	1
ISSN	0022-1899
DOIs	https://doi.org/10.1093/infdis/jiaf199
Publication status	E-pub ahead of print - 2025

Access to Document

10.1093/infdis/jiaf199Licence: CC BY

Cite this

@article{0fe5182fcba641398b994ba1a9945c3a,

title = "The available evidence does not support the claim of Nitikin et al that 4CMenB is a cost-effective way to reduce Gonorrhea incidence",

author = "C Kenyon",

year = "2025",

doi = "10.1093/infdis/jiaf199",

language = "English",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - The available evidence does not support the claim of Nitikin et al that 4CMenB is a cost-effective way to reduce Gonorrhea incidence

AU - Kenyon, C

PY - 2025

Y1 - 2025

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=itm_wosliteitg&SrcAuth=WosAPI&KeyUT=WOS:001477458100001&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1093/infdis/jiaf199

DO - 10.1093/infdis/jiaf199

M3 - Letter

SN - 0022-1899

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

ER -

The available evidence does not support the claim of Nitikin et al that 4CMenB is a cost-effective way to reduce Gonorrhea incidence

Access to Document

Other files and links

Cite this